ALD403

Shares of Alder Biopharmaceuticals Inc (NASDAQ: ALDR) were trading lower by nearly 4 percent early Thursday morning after the company announced a public offering of its common stock. Alder Biopharmaceuticals said it will offer 5.376 million shares of its stock at a price of $23.25 per share....

Shares of Alder Biopharmaceuticals Inc (NASDAQ: ALDR), a clinical-stage biopharmaceutical company, surged higher by nearly 60 percent on Monday. Alder Biopharmaceuticals announced earlier in the morning positive top-line data from 2 clinical trials which studied its ALD403 product, an antibody...